OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...

OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") , a bio-analytical based women's ...

HC Wainwright reiterated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has ...

OPKO Health (NASDAQ: OPK) has recently received a number of price target changes and ratings updates: 3/19/2025 – OPKO Health ...

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side ...

根据声明，融资后，Mito Health的融资总额达到了近400万美元。同时，该公司也在声明中指出，将利用这笔资金打造基于AI技术的健康预防产品。 Mito Health成立于23年 前后 ，旨在打造出一个通过强调预防措施和早期发现来保证人们健康的医疗健康系统。在具体落地层面，Mito ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is ...

LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses The IGNITE study, which evaluated two dose strengths of ...

In September 2024, OPKO Health, Inc. (NASDAQ:OPK) sold a portion of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health for a purchase price ...

Patient safety is a vital component of achieving the best possible health outcomes, ensuring that serious injuries and complications are minimized for patients during hospital stays. U.S. FDA approves ...

Patient safety is a vital component of achieving the best possible health outcomes, ensuring that serious injuries and complications are minimized for patients during hospital stays. U.S. FDA approves ...